Periodic Reporting for period 3 - RespiriTB (Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors)

Mycobacterium tuberculosis (Mtb) causes tuberculosis (TB), a debilitating disease that causes over 1.5 million deaths each year, more than any other infectious disease such as HIV, malaria, or cholera. The currently available antibiotics against Mtb require a lengthy treatment...